Special Issue "Advances in Ocular Pharmacology"
Deadline for manuscript submissions: 30 September 2020.
Interests: cataract; epigenetics; nanotechnology
Interests: medical research; glaucoma; cataract; cornea
Interests: pediatric ophthalmology ; strabismus; nanotechnology
Ocular pharmacology is a field that has grown rapidly during the last few years, as we have witnessed several new and promising treatments becoming available for eye disorders that are not amenable to surgery, including age-related macular degeneration (AMD), branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), diabetic macular edema (DME), retinitis pigmentosa (RP), and virus infections.
The eye is an organ protected from environmental stress and obnoxious substances by various barriers, a fact that necessitates innovation in the administration route of pharmaceutical substances. Recently several innovative technologies have been developed to directly reach the vitreous chamber or the retina. Those include intravitreal injections of anti-vascular endothelial growth factor and direct intravitreal implants, using biodegradable or non-biodegradable polymer technology.
This Special Issue will summarize the state-of-the-art, and the latest findings published in the ocular pharmacology field, as well as to provide directions for future research.
Prof. Ioannis Tsinopoulos
Dr. Ioanna Mylona
Dr. Lampros Lamprogiannis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- ocular pharmacology
- drug delivery systems